With the recent adoption of federal regulations governing the medical use of radioactive material, the Radiation Safety Committee (RSC) would like to remind all clinical users of radioactive material of the requirements for the timely identification and reporting of medical events. Please see the attached document for specific criteria and reporting requirements.
Message from Vice Chancellor for Research James Economou
Vice Chancellor for Research James Economou sent a Deans and Directors Memo on May 1, 2012 regarding the reorganization of UCLA’s Radiation Safety Program and summary of goals for the coming year. Please see the attached document for the complete text.
Regulatory Guidance for PET Radiopharmaceuticals
Regulatory guidance went into effect December 12, 2011 regarding positron emission tomography (PET) radiopharmaceuticals used in clinical and research procedures. As of that date, production of PET radiopharmaceuticals must comply with Current Good Manufacturing Practices (cGMP) and/or USP chapter 823 guidelines and thus should be reflected in the MRSC/RDRC protocol reviews. For more information about the changes, please see the … Read More
Radiation Safety Committee Reorganization
At the request of Vice Chancellor for Research James Economou, the Radiation Safety Committee and subcommittees underwent reorganization in 2011 in order to better fulfill UCLA’s regulatory obligations and to enhance radiation safety for faculty, staff, students and patients. The Office of the Radiation Safety Committees (ORSC) was created to provide administrative support for each of these important committees. As … Read More